Relationship between NAD(P)H:quinone oxidoreductase 1 (NQO1) levels in a series of stably transfected cell lines and susceptibility to antitumor quinones

被引:77
作者
Winski, SL
Swann, E
Hargreaves, RHJ
Dehn, DL
Butler, J
Moody, CJ
Ross, D
机构
[1] Univ Colorado, Sch Pharm, Dept Pharmaceut Sci, Hlth Sci Ctr, Denver, CO 80262 USA
[2] Univ Colorado, Ctr Canc, Denver, CO 80262 USA
[3] Univ Exeter, Exeter, Devon, England
[4] Christie Res Ctr, Manchester, Lancs, England
[5] Univ Salford, Dept Biol Sci, Salford M5 4WT, Lancs, England
关键词
NQO1; antitumor quinones; enzyme-directed drug development; preclinical research; in vitro testing;
D O I
10.1016/S0006-2952(01)00631-1
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
To investigate the importance of NAD(P)H:quinone oxidoreductase 1 (or DT-diaphorase; NQO1) in the bioactivation of antitumor quinones, we established a series of stably transfected cell lines derived from BE human colon adenocarcinoma cells. BE cells have no NQO1 activity due to a genetic polymorphism. The new cell lines, BE-NQ, stably express wild-type NQO1. BE-NQ7 cells expressed the highest level of NQO1 and were more susceptible [determined by the thiazolyl blue (MTT) assay] to known antitumor quinones and newer clinical candidates. Inhibition of NQO1 by pretreatment with an irreversible inhibitor, ES936 [5-methoxy-1,2-dimethyl-3-[(4-nitrophenoxy)methyl]indole-4,7-dione], protected BE-NQ7 cells from toxicity induced by streptonigrin, ES921 [5-(aziridin-1-yl)-3-(hydroxymethyl)-1,2-dimethylindole-4,7-dione], and RH1 [2,5-diaziridinyl-3-(hydroxymethyl)-6-methyl-benzoquinone]. RH1 was evaluated further by clonogenic assay for cytotoxic response and was more cytotoxic to BE-NQ7 cells than to BE cells. Cytotoxicity was abrogated by inhibition of NQO1 with ES936 pretreatment. Using a comet assay to evaluate DNA cross-linking, BE-NQ7 cells demonstrated significantly higher DNA cross-links than did BE cells in response to RH1 treatment. DNA cross-linking in BE-NQ7 cells was observed at very low concentrations of RH1 (5 nM), confirming that NQO1 activates RH1 to a potent cross-linking species. Further studies using streptonigrin, ES921, and RH1 were undertaken to analyze the relationship between NQO1 activity and quinone toxicity. Toxicity of these compounds was measured in a panel of BE-NQ cells expressing a range of NQO1 activity (23-433 nmol/min/mg). Data obtained suggest a threshold for NQO1-induced toxicity above 23 nmol/min/mg and a sharp dose-response curve between the no effect level of NQO1 (23 nmol/min/mg) and the maximal effect level (> 77 nmol/min/mg). These data provide evidence that NQO1 can bioactivate antitumor quinones in this system and suggest that a threshold level of NQO1 activity is required to initiate toxic events. (C) 2001 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:1509 / 1516
页数:8
相关论文
共 47 条
[1]   Indolequinone antitumor agents: Relationship between quinone structure and rate of metabolism by recombinant human NQO1 [J].
Beall, HD ;
Hudnott, AR ;
Winski, S ;
Siegel, D ;
Swann, E ;
Ross, D ;
Moody, CJ .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1998, 8 (05) :545-548
[2]   Indolequinone antitumor agents:: Correlation between quinone structure, rate of metabolism by recombinant human NAD(P)H:quinone oxidoreductase, and in vitro cytotoxicity [J].
Beall, HD ;
Winski, S ;
Swann, E ;
Hudnott, AR ;
Cotterill, AS ;
O'Sullivan, N ;
Green, SJ ;
Bien, R ;
Siegel, D ;
Ross, D ;
Moody, CJ .
JOURNAL OF MEDICINAL CHEMISTRY, 1998, 41 (24) :4755-4766
[3]  
BEALL HD, 1995, MOL PHARMACOL, V48, P499
[4]   INCREASE OF NAD(P)H-QUINONE REDUCTASE BY DIETARY ANTIOXIDANTS - POSSIBLE ROLE IN PROTECTION AGAINST CARCINOGENESIS AND TOXICITY [J].
BENSON, AM ;
HUNKELER, MJ ;
TALALAY, P .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1980, 77 (09) :5216-5220
[5]  
BLIGH HFJ, 1990, CANCER RES, V50, P7789
[6]  
Brown JM, 1997, ONCOL RES, V9, P213
[7]   DT-DIAPHORASE-CATALYZED REDUCTION OF 1,4-NAPHTHOQUINONE DERIVATIVES AND GLUTATHIONYL-QUINONE CONJUGATES [J].
BUFFINTON, GD ;
OLLINGER, K ;
BRUNMARK, A ;
CADENAS, E .
BIOCHEMICAL JOURNAL, 1989, 257 (02) :561-571
[8]   POTENTIAL CENTRAL NERVOUS-SYSTEM ANTITUMOR AGENTS - AZIRIDINYLBENZOQUINONES .2. [J].
CHOU, F ;
KHAN, AH ;
DRISCOLL, JS .
JOURNAL OF MEDICINAL CHEMISTRY, 1976, 19 (11) :1302-1308
[9]   HIGH-LEVELS OF EXPRESSION OF THE NAD(P)H-QUINONE OXIDOREDUCTASE (NQO1) GENE IN TUMOR-CELLS COMPARED TO NORMAL-CELLS OF THE SAME ORIGIN [J].
CRESTEIL, T ;
JAISWAL, AK .
BIOCHEMICAL PHARMACOLOGY, 1991, 42 (05) :1021-1027
[10]   MITOMYCIN-C - REVIEW [J].
CROOKE, ST ;
BRADNER, WT .
CANCER TREATMENT REVIEWS, 1976, 3 (03) :121-139